Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 1958 entries
View as:

A Study in Older Participants Who Have Fallen and Have Muscle Weakness

Phase: N/A Priority: Normal
NCT ID: NCT01604408 Org: User:
Start: 05/31/12 End: 12/31/13 Due: 12/31/14

A Study of the Absorption, Distribution, Metabolism and Excretion of LY3039478 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02917733 Org: User:
Start: 09/30/16 End: 11/30/16 Due: 11/30/17

A Comparison of LY2963016 to a Basal Insulin After a Single Dose in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01374178 Org: User:
Start: 06/30/11 End: 07/31/11 Due: 07/31/12

A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00965419 Org: User:
Start: 09/30/09 End: 07/31/15 Due: 07/31/16

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03311724 Org: User:
Start: 10/19/17 End: 04/24/18 Due: 04/24/19

A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03322631 Org: User:
Start: 11/15/17 End: 11/28/18 Due: 11/28/19

Study of LY3039478 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02906618 Org: User:
Start: 10/04/16 End: 11/11/16 Due: 11/11/17

A Study of Pemetrexed in Children With Recurrent Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00520936 Org: User:
Start: 09/30/07 End: 02/28/10 Due: 02/28/11

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT05275400 Org: User:
Start: 03/08/22 End: 05/15/24 Due: 05/15/25

A Study of LY2963016 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01634165 Org: User:
Start: 07/31/12 End: 09/30/12 Due: 09/30/13

Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02792725 Org: User:
Start: - End: - Due: -

24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine

Phase: N/A Priority: Normal
NCT ID: NCT00551538 Org: User:
Start: 05/31/03 End: 12/31/04 Due: 12/31/05

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00383422 Org: User:
Start: 10/31/06 End: 07/31/08 Due: 07/31/09

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT00343291 Org: User:
Start: 12/31/06 End: 12/31/10 Due: 12/31/11

A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Phase: N/A Priority: Normal
NCT ID: NCT02754830 Org: User:
Start: 04/25/16 End: 07/10/18 Due: 07/10/19

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT05086289 Org: User:
Start: 10/25/21 End: 06/17/22 Due: 06/17/23

A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT02156492 Org: User:
Start: 06/30/14 End: 12/31/14 Due: 12/31/15

A Study of Evacetrapib in Participants With Abnormal Cholesterol

Phase: N/A Priority: Normal
NCT ID: NCT02168803 Org: User:
Start: 05/31/14 End: 12/31/15 Due: 12/31/16

A Study of LY4065967 in Healthy Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06594159 Org: User:
Start: 10/22/24 End: 03/11/25 Due: 03/11/26

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

Phase: N/A Priority: Normal
NCT ID: NCT00547183 Org: User:
Start: 10/31/04 End: 05/31/05 Due: 05/31/06

An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT01914666 Org: User:
Start: 09/30/13 End: 12/31/14 Due: 12/31/15

A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).

Phase: N/A Priority: Normal
NCT ID: NCT02431754 Org: User:
Start: 04/30/15 End: 02/29/16 Due: 02/28/17

A Study of LY2157299 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT01965808 Org: User:
Start: 10/31/13 End: 12/31/13 Due: 12/31/14

A Study of LY3375880 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03343587 Org: User:
Start: 11/17/17 End: 11/16/18 Due: 11/16/19

Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00065533 Org: User:
Start: 05/31/03 End: 06/30/05 Due: 06/30/06